Viewing Study NCT04522895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2025-12-26 @ 4:48 AM
Study NCT ID: NCT04522895
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2020-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT
Sponsor: Heinrich-Heine University, Duesseldorf
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Acute View
None Myelodysplastic Syndromes View
None Chronic Myelomonocytic Leukemia View
None IDH2 Gene Mutation View
None IDH2 R172 View
None IDH2 R140 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IDH2 Gene Mutation View
None MDS View
None CMML View
None AML View
None allogeneic blood stem cell transplantation View
None maintenance View
None consolidation View